The Innovative Pharmaceutical Association South Africa (IPASA), which represents 25 leading innovative pharmaceutical companies dedicated to exploring, developing and bringing innovative, quality medicines to South Africa, has appointed Tribeca as its PR agency.
The partnership aims to enhance the industry body’s reputation among stakeholders - including policymakers, healthcare professionals and the public - through strategic and impactful communications that advocate for and contribute towards better healthcare, economic growth and societal progress in South Africa.
“IPASA has long played a critical role in advancing healthcare innovation in South Africa. As the industry continues to evolve, we have recognised the need to go beyond brand visibility and move toward actively shaping conversations around the transformative value of pharmaceutical innovation. We believe Tribeca Public Relations has the strategic approach and experience to support us on this mission,” says Bada Pharasi, CEO of IPASA.
“A strong pharmaceutical industry means better access to life-saving medicines, more jobs, and a healthier population. We’re excited to work with the IPASA team and help more people realise that research and development investment drives shared value and innovation. This translates into affordable and new treatments available to patients, boosted economies and improved overall quality of life,” says Kelly Mossop, Business Unit Director at Tribeca Public Relations.